NEOPAP Drug Patent Profile
When do Neopap patents expire, and when can generic versions of Neopap launch?
Neopap is a drug marketed by Polymedica and is included in one NDA.
The generic ingredient in NEOPAP is acetaminophen. There is one drug master file entry for this compound. Ninety-three suppliers are listed for this compound. Additional details are available on the acetaminophen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Neopap
A generic version of NEOPAP was approved as acetaminophen by PERRIGO on February 25th, 2000.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NEOPAP?
- What are the global sales for NEOPAP?
- What is Average Wholesale Price for NEOPAP?
Summary for NEOPAP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 145 |
| Patent Applications: | 3,928 |
| DailyMed Link: | NEOPAP at DailyMed |
US Patents and Regulatory Information for NEOPAP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Polymedica | NEOPAP | acetaminophen | SUPPOSITORY;RECTAL | 016401-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
